Cognitive functioning associated with acute and subacute effects of classic psychedelics and MDMA - a systematic review and meta-analysis.

Autor: Basedow LA; Department of Psychology, Clinical Psychology and Psychotherapy, Philipps-Universität Marburg, Gutenbergstraße 18, 35037, Marburg, Germany. lukas.basedow@uni-marburg.de., Majić T; Psychedelic Substances Research Group, Department of Psychiatry and Neurosciences, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Department of Psychiatry und Neurosciences, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Hafiz NJ; Institute for Educational Quality Improvement (IQB), Humboldt-Universität zu Berlin, Berlin, Germany., Algharably EAE; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Clinical Pharmacology and Toxicology, Charité Campus Mitte, Charitéplatz 1, 10117, Berlin, Germany., Kreutz R; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Clinical Pharmacology and Toxicology, Charité Campus Mitte, Charitéplatz 1, 10117, Berlin, Germany., Riemer TG; Psychedelic Substances Research Group, Department of Psychiatry and Neurosciences, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Clinical Pharmacology and Toxicology, Charité Campus Mitte, Charitéplatz 1, 10117, Berlin, Germany.

Publikováno v: Scientific reports [Sci Rep] 2024 Jun 26; Vol. 14 (1), pp. 14782. Date of Electronic Publication: 2024 Jun 26.

Psychiatric Adverse Events of Acetylcholinesterase Inhibitors in Alzheimer's Disease and Parkinson's Dementia: Systematic Review and Meta-Analysis.

Autor: Bittner N; Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117, Berlin, Germany. nadine.bittner@charite.de., Funk CSM; Institute of Clinical Pharmacology and Toxicology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10115, Berlin, Germany., Schmidt A; Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany., Bermpohl F; Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117, Berlin, Germany., Brandl EJ; Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117, Berlin, Germany., Algharably EEA; Institute of Clinical Pharmacology and Toxicology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10115, Berlin, Germany., Kreutz R; Institute of Clinical Pharmacology and Toxicology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10115, Berlin, Germany., Riemer TG; Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117, Berlin, Germany. thomas.riemer@charite.de.; Institute of Clinical Pharmacology and Toxicology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10115, Berlin, Germany. thomas.riemer@charite.de.

Publikováno v: Drugs & aging [Drugs Aging] 2023 Nov; Vol. 40 (11), pp. 953-964. Date of Electronic Publication: 2023 Sep 08.

Trail Making Test Error Analysis in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Dementia With and Without Depression.

Autor: Hafiz NJ; Department of Clinical Psychology, Humboldt-Universität zu Berlin, Berlin, Germany., Lohse A; Charité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Psychiatry and Psychotherapy, Berlin, Germany., Haas R; Department of Clinical Psychiatry, Social Psychiatry, and Psychotherapy, Hannover Medical School, Hannover, Germany., Reiche S; Charité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Psychiatry and Psychotherapy, Berlin, Germany., Sedlaczek L; Department of Clinical Psychology, Humboldt-Universität zu Berlin, Berlin, Germany., Brandl EJ; Charité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Psychiatry and Psychotherapy, Berlin, Germany., Riemer TG; Charité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Psychiatry and Psychotherapy, Berlin, Germany.; Charité - Universitätsmedizin Berlin Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Clinical Pharmacology and Toxicology, Berlin, Germany.

Publikováno v: Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists [Arch Clin Neuropsychol] 2023 Jan 21; Vol. 38 (1), pp. 25-36.

Systematic review and meta-analysis on the therapeutic reference range for escitalopram: Blood concentrations, clinical effects and serotonin transporter occupancy.

Autor: Eichentopf L; Department of Molecular Neuroimaging, Medical Faculty Mannheim, Central Institute of Mental Health, Heidelberg University, Mannheim, Germany., Hiemke C; Department of Psychiatry and Psychotherapy, Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center of Mainz, Mainz, Germany.; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP)-Work Group 'Therapeutic Drug Monitoring', Nürnberg, Germany., Conca A; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP)-Work Group 'Therapeutic Drug Monitoring', Nürnberg, Germany.; Department of Psychiatry, Central Hospital, Sanitary Agency of South Tyrol, Bolzano, Italy., Engelmann J; Department of Psychiatry and Psychotherapy, Johannes Gutenberg University Medical Center Mainz, Mainz, Germany., Gerlach M; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP)-Work Group 'Therapeutic Drug Monitoring', Nürnberg, Germany.; Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital Würzburg, Würzburg, Germany., Havemann-Reinecke U; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP)-Work Group 'Therapeutic Drug Monitoring', Nürnberg, Germany.; Department of Psychiatry and Psychosomatics, University of Göttingen, Göttingen, Germany., Hefner G; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP)-Work Group 'Therapeutic Drug Monitoring', Nürnberg, Germany.; Vitos Clinic for Forensic Psychiatry, Forensic Psychiatry, Eltville, Germany., Florio V; Department of Psychiatry, Comprensorio Sanitario di Bolzano, Bolzano, Italy., Kuzin M; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP)-Work Group 'Therapeutic Drug Monitoring', Nürnberg, Germany.; Clienia Schlössli AG, Psychiatric and Psychotherapeutic Private Clinic, Academic Teaching Hospital of the University of Zurich, Oetwil am See, Switzerland., Lieb K; Department of Psychiatry and Psychotherapy, University Medical Center Mainz, Mainz, Germany., Reis M; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.; Department of Clinical Chemistry and Pharmacology, Skåne University Hospital, Lund, Sweden., Riemer TG; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Clinical Pharmacology and Toxicology, Berlin, Germany., Serretti A; Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy., Schoretsanitis G; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP)-Work Group 'Therapeutic Drug Monitoring', Nürnberg, Germany.; Department of Psychiatry, Psychotherapy and Psychosomatics, Hospital of Psychiatry, University of Zurich, Zurich, Switzerland.; Department of Psychiatry, Behavioral Health Pavilion, Northwell Health, The Zucker Hillside Hospital, Glen Oaks, NY, United States.; Department of Psychiatry, Zucker School of Medicine at Northwell/Hofstra, Hempstead, NY, United States., Zernig G; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP)-Work Group 'Therapeutic Drug Monitoring', Nürnberg, Germany.; Department of Pharmacology, Medical University of Innsbruck, Innsbruck, Austria.; Private Practice for Psychotherapy and Court-Certified Witness, Hall in Tirol, Austria., Gründer G; Department of Molecular Neuroimaging, Medical Faculty Mannheim, Central Institute of Mental Health, Heidelberg University, Mannheim, Germany.; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP)-Work Group 'Therapeutic Drug Monitoring', Nürnberg, Germany., Hart XM; Department of Molecular Neuroimaging, Medical Faculty Mannheim, Central Institute of Mental Health, Heidelberg University, Mannheim, Germany.; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP)-Work Group 'Therapeutic Drug Monitoring', Nürnberg, Germany.

Publikováno v: Frontiers in psychiatry [Front Psychiatry] 2022 Oct 17; Vol. 13, pp. 972141. Date of Electronic Publication: 2022 Oct 17 (Print Publication: 2022).

Erratum to: Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19: European Society of Hypertension COVID-19 Task Force Review of Evidence.

Autor: Kreutz R, Algharably EAE, Azizi M, Dobrowolski P, Guzik T, Januszewicz A, Persu A, Prejbisz A, Riemer TG, Wang JG, Burnier M

Publikováno v: Cardiovascular research [Cardiovasc Res] 2021 Sep 28; Vol. 117 (11), pp. 2394.